MedPath

Comparison of Sublingual Misoprostol and Intravenous Oxytocin in Active Management of the Third Stage of Labor

Conditions
Postpartum Hemorrhage Prevention by Using Oxytocin Verses Misoprostol
Registration Number
NCT01612390
Lead Sponsor
Rasha Mohammed Mohammed Badawi
Brief Summary

Sublingual misoprostol is superior to oxytocin in reduction of blood loss during the third and fourth stages of labor

Detailed Description

Sublingual misoprostol is superior to oxytocin in reduction of blood loss during the third and fourth stages of labor as The data from a pharmacokinetics study suggested that the bioavaiblitiy of misoprostol after sub-lingual administration was higher than those after oral or vaginal administration

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
180
Inclusion Criteria
  • Women with aheathy singleton pregnancy in spontaneous or induced labor at term .
Exclusion Criteria
  • Hypersensitivity/Contraindication to prostaglandins Antepartum hemorrhage Multiple pregnancy Cardiac disease Malpresentation Rhesus- negative mother hypersensitive disorders Severe anaemia(hemoglobin<7g/dl)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reduce blood loss during third and fourth stages of labor.1 year

reduce blood loss during third and fourth stages of labor by using misopristol is better than using oxytocin

Secondary Outcome Measures
NameTimeMethod
the duration of the third stage of labor ,need for oxytocics ,blood transfusion and any adverse effects of the drugs1 year

the duration of the third stage of labor ,needed for oxytocics ,blood transfusion and any adverse effects of the drug will be reduced with mesopristol

Trial Locations

Locations (1)

AinShamsU

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath